Solstice Advanced Materials Inc. (SOLS) Spending and interest coverage
- R&D / revenue · 12 months: Value 2.56%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.63%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 2.56% | Research and development expense / revenue. Period ending 2026-06-30. $105.00M ÷ $4.09B × 100 ≈ 2.56% |
| Stock-based compensation / revenue · 12 months | 0.63% | Share-based compensation / revenue. Period ending 2026-06-30. $26.00M ÷ $4.09B × 100 ≈ 0.63% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 105.00M USD | Research and Development Expense |
| Revenue | 4.09B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 26.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $105.00M | $4.09B | $26.00M | (m) | (m) | 2.56% | 0.63% | (m) | (m) |
| 2026-03-31 | $103.00M | $3.98B | $26.00M | (m) | (m) | 2.59% | 0.65% | (m) | (m) |
| 2025-12-31 | $97.00M | $3.89B | $27.00M | (m) | (m) | 2.50% | 0.69% | (m) | (m) |
| 2025-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $83.00M | $3.77B | $17.00M | (m) | (m) | 2.20% | 0.45% | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $81.00M | $3.65B | $18.00M | (m) | (m) | 2.22% | 0.49% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BALCHEM CORP (BCPC) | United States | $5.347B | 32.84 |
| Perimeter Solutions, Inc. (PRM) | $4.593B | -17.21 | |
| Ingevity Corp (NGVT) | United States | $2.468B | 47.72 |
| INNOSPEC INC. (IOSP) | United States | $2.380B | 16.37 |
| Chemours Co (CC) | United States | $2.136B | -10.64 |
| OLIN Corp (OLN) | United States | $1.852B | -11.54 |
| Huntsman CORP (HUN) | United States | $1.540B | -6.95 |
| FMC CORP (FMC) | United States | $1.201B | -0.52 |
| Ecovyst Inc. (ECVT) | United States | $1.110B | -22.22 |
| ASCENT INDUSTRIES CO. (ACNT) | United States | $0.132B | -30.55 |